Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-28 pm EDT 		5-day change 1st Jan Change
20.98 USD -0.05% Intraday chart for Organon & Co. -3.98% +45.49%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on Organon & Co.

2024-05-09 Quarterly 0.28 USD
2024-02-22 Quarterly 0.28 USD
2023-11-09 Quarterly 0.28 USD
2023-08-16 Quarterly 0.28 USD
2023-05-11 Quarterly 0.28 USD
2023-02-23 Quarterly 0.28 USD
2022-11-09 Quarterly 0.28 USD
2022-08-11 Quarterly 0.28 USD
2022-05-12 Quarterly 0.28 USD
2022-02-24 Quarterly 0.28 USD
2021-11-18 Quarterly 0.28 USD
2021-08-19 Quarterly 0.28 USD
  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Charts Organon & Co.
  5. Total Return chart